1.1 Articolo in rivista

1.1 Articolo in rivista: [27914] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 3.901 a 3.920 di 27.914

Bictegravir/emtricitabine/tenofovir alafenamide-induced acute pancreatitis: a case report

2020-01-01 Riva, A; Cattaneo, D; Filice, C; Gervasoni, C.

Telaprevir therapy, renal impairment, and their effects on the pharmacokinetics of tenofovir in HIV/hepatitis C virus coinfected patients

2014-01-01 Gervasoni, C; Milazzo, L; Pezzani, D; Fucile, S; Cattaneo, D

Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring

2015-01-01 Gervasoni, C.; Terzi, R.; Heidempergher, M.; Clementi, E.; Cattaneo, D.

Dolutegravir dosing with rifampicin

2023-01-01 Cattaneo, D; Gervasoni, C

Kidney Injury Molecule 1: In Search of Biomarkers of Chronic Tubulointerstitial Damage and Disease Progression

2009-01-01 Perico, Norberto; Cattaneo, D; Remuzzi, Giuseppe

Management of Polypharmacy and Potential Drug-Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic

2024-01-01 Cattaneo, Dario; Torre, Alessandro; Schiuma, Marco; Civati, Aurora; Casalini, Giacomo; Gori, Andrea; Antinori, Spinello; Gervasoni, Cristina

When the absence of an interaction can become clinically relevant

2021-01-01 Cattaneo, D; Bernacchia, D; Beltrami, M; Resnati, C; Meraviglia, P; Gervasoni, C.

Tenofovir Plasma Trough Concentrations in People Living with HIV Treated with Tenofovir Disoproxyl Fumarate: Antiretroviral Class or Individual Drug Effect?

2023-01-01 Cattaneo, D; Bonora, S; Meraviglia, P; Vimercati, S; Antinori, S; Gervasoni, C

A three-in-one, long-acting, nanosuspension reformulation of off-patent antiretrovirals for low-income and middle-income countries

2018-01-01 Cattaneo, D; Perno, Cf; Rizzardini, G

High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis

2018-01-01 Arsiè, Elena; Piconi, Stefania; Iavarone, Massimo; Cozzi, Valeria; Lampertico, Pietro; Cattaneo, Dario

Intolerance of dolutegravir-containing combination antiretroviral therapy: not just a pharmacokinetic drug interaction

2017-01-01 Cattaneo, D; Rizzardini, G; Gervasoni, C

Application Of Quality By Design Approach To Bioanalysis: Development Of A Method For Elvitegravir Quantification In Human Plasma

2017-01-01 Baldelli, S; Marrubini, G; Cattaneo, D; Clementi, E; Cerea, M.

Pharmacokinetics of mycophenolate sodium and comparison with the mofetil transplant recipients formulation in stable kidney

2007-01-01 Cattaneo, D; Cortinovis, Monica; Baldelli, Sara; Bitto, Alessandra; Gotti, Eliana; Remuzzi, Giuseppe; Perico, Norberto

Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients

2015-01-01 Gervasoni, C.; Riva, A.; Rizzardini, G.; Clementi, E.; Galli, M.; Cattaneo, D.

Optimizing immunosuppressive drug dosing in pediatric renal transplantation

2012-01-01 Cattaneo, D; Vinks Alexander, A.

Immune deficiency is a risk factor for severe COVID-19 in people living with HIV

2021-01-01 Hoffmann, C; Casado, Jl; Härter, G; Vizcarra, P; Moreno, A; Cattaneo, D; Meraviglia, P; Spinner, Cd; Schabaz, F; Grunwald, S; Gervasoni, C.

Potential association between chia seeds use and low atazanavir trough concentrations in an HIV-infected patient

2023-01-01 Cattaneo, D; Pagano, S; Beltrami, M; Micheli, V; Gervasoni, C.

Why Product Information Should not be Set in Stone: Lessons from a Decade of Linezolid Therapeutic Drug Monitoring: An Opinion Paper

2023-01-01 Marriott, Dje; Cattaneo, D

Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?

2017-01-01 Cattaneo, D; Minisci, D; Cozzi, V; Riva, A; Meraviglia, P; Clementi, E; Galli, M; Gervasoni, C.

Whole-blood calcineurin activity is not predicted by cyclosporine blood concentration in renal transplant recipients

2001-01-01 Caruso, R; Perico, N; Cattaneo, D; Piccinini, G; Bonazzola, S; Remuzzi, G; Gaspari, F

Titolo	Data di pubblicazione	Autore(i)
Bictegravir/emtricitabine/tenofovir alafenamide-induced acute pancreatitis: a case report	1-gen-2020	Riva, A; Cattaneo, D; Filice, C; Gervasoni, C.
Telaprevir therapy, renal impairment, and their effects on the pharmacokinetics of tenofovir in HIV/hepatitis C virus coinfected patients	1-gen-2014	Gervasoni, C; Milazzo, L; Pezzani, D; Fucile, S; Cattaneo, D
Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring	1-gen-2015	Gervasoni, C.; Terzi, R.; Heidempergher, M.; Clementi, E.; Cattaneo, D.
Dolutegravir dosing with rifampicin	1-gen-2023	Cattaneo, D; Gervasoni, C
Kidney Injury Molecule 1: In Search of Biomarkers of Chronic Tubulointerstitial Damage and Disease Progression	1-gen-2009	Perico, Norberto; Cattaneo, D; Remuzzi, Giuseppe
Management of Polypharmacy and Potential Drug-Drug Interactions in Patients with Pulmonary Aspergillosis: A 2-Year Study of a Multidisciplinary Outpatient Clinic	1-gen-2024	Cattaneo, Dario; Torre, Alessandro; Schiuma, Marco; Civati, Aurora; Casalini, Giacomo; Gori, Andrea; Antinori, Spinello; Gervasoni, Cristina
When the absence of an interaction can become clinically relevant	1-gen-2021	Cattaneo, D; Bernacchia, D; Beltrami, M; Resnati, C; Meraviglia, P; Gervasoni, C.
Tenofovir Plasma Trough Concentrations in People Living with HIV Treated with Tenofovir Disoproxyl Fumarate: Antiretroviral Class or Individual Drug Effect?	1-gen-2023	Cattaneo, D; Bonora, S; Meraviglia, P; Vimercati, S; Antinori, S; Gervasoni, C
A three-in-one, long-acting, nanosuspension reformulation of off-patent antiretrovirals for low-income and middle-income countries	1-gen-2018	Cattaneo, D; Perno, Cf; Rizzardini, G
High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis	1-gen-2018	Arsiè, Elena; Piconi, Stefania; Iavarone, Massimo; Cozzi, Valeria; Lampertico, Pietro; Cattaneo, Dario
Intolerance of dolutegravir-containing combination antiretroviral therapy: not just a pharmacokinetic drug interaction	1-gen-2017	Cattaneo, D; Rizzardini, G; Gervasoni, C
Application Of Quality By Design Approach To Bioanalysis: Development Of A Method For Elvitegravir Quantification In Human Plasma	1-gen-2017	Baldelli, S; Marrubini, G; Cattaneo, D; Clementi, E; Cerea, M.
Pharmacokinetics of mycophenolate sodium and comparison with the mofetil transplant recipients formulation in stable kidney	1-gen-2007	Cattaneo, D; Cortinovis, Monica; Baldelli, Sara; Bitto, Alessandra; Gotti, Eliana; Remuzzi, Giuseppe; Perico, Norberto
Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients	1-gen-2015	Gervasoni, C.; Riva, A.; Rizzardini, G.; Clementi, E.; Galli, M.; Cattaneo, D.
Optimizing immunosuppressive drug dosing in pediatric renal transplantation	1-gen-2012	Cattaneo, D; Vinks Alexander, A.
Immune deficiency is a risk factor for severe COVID-19 in people living with HIV	1-gen-2021	Hoffmann, C; Casado, Jl; Härter, G; Vizcarra, P; Moreno, A; Cattaneo, D; Meraviglia, P; Spinner, Cd; Schabaz, F; Grunwald, S; Gervasoni, C.
Potential association between chia seeds use and low atazanavir trough concentrations in an HIV-infected patient	1-gen-2023	Cattaneo, D; Pagano, S; Beltrami, M; Micheli, V; Gervasoni, C.
Why Product Information Should not be Set in Stone: Lessons from a Decade of Linezolid Therapeutic Drug Monitoring: An Opinion Paper	1-gen-2023	Marriott, Dje; Cattaneo, D
Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?	1-gen-2017	Cattaneo, D; Minisci, D; Cozzi, V; Riva, A; Meraviglia, P; Clementi, E; Galli, M; Gervasoni, C.
Whole-blood calcineurin activity is not predicted by cyclosporine blood concentration in renal transplant recipients	1-gen-2001	Caruso, R; Perico, N; Cattaneo, D; Piccinini, G; Bonazzola, S; Remuzzi, G; Gaspari, F

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 3.901 a 3.920 di 27.914

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext25661
reserved1362
open891